I refer to recent correspondence regarding pharmaceutical advertising from Anthony Cox of the West Midlands Centre for Adverse Drug Reaction Reporting (PJ, 1 February, p154) who was responding to Professor Trevor Jones, Director General of the Association of the British Pharmaceutical Industry (PJ, 25 January, p116).
展开▼